About The Medical Condition EN-1639A

ClusterMed

Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

EN-1639A

EN-1639A Medical Condition Defined & Explained
EN-1639A Medical Condition

What's The Definition Of The Medical Condition EN-1639A?

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day